Sleep apnea is a common sleep disorder that affects more than 20 ... side — and stop you from rolling over onto your back ...

Vivos Therapeutics is a pioneering medical device and technology company focused on addressing sleep-related breathing disorders (SRBDs), particularly obstructive sleep apnea (OSA). Their flagship ...

Vivos Therapeutics (NASDAQ: VVOS), a leading medical-device and technology company specializing in the development and commercialization of highly effective proprietary treatments for sleep-related ...

Vivos is poised to disrupt the very significant pediatric obstructive sleep apnea (OSA) market with new FDA clearance and new strategic marketing ...

It is likely most cost-effective to have the procedure performed at a hospital outpatient surgery center that accepts the Medicare-approved procedure cost. The out-of-pocket cost for the Inspire sleep ...

Surgery to remove the tonsils and adenoids (known as adenotonsillectomy) is an effective first-line treatment for obstructive sleep apnea in children. Additional surgical procedures may also help ...

An estimated 20 to 30 million people in the United States are living with undiagnosed moderate to severe sleep apnea, ...

Early diagnosis and treatment of obstructive sleep apnea (OSA) may lead to better outcomes in infants with Down syndrome.

An epilepsy drug could cure a potentially deadly snoring condition, suggests a new study. Patients taking sulthiame - currently used for childhood epilepsy - in a clinical trial experienced a ...

A common childhood epilepsy drug has the potential to change the lives of millions of people who suffer from sleep apnea, as ...

Patients taking sulthiame, a drug currently in use for epilepsy, experienced a reduction in their symptoms of obstructive ...

Sleep apnea affects nearly 40 million adults in the U.S., with many relying on continuous positive airway pressure (CPAP) ...